rs747229909
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_017882.3(CLN6):c.445C>T(p.Arg149Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLN6 | NM_017882.3 | c.445C>T | p.Arg149Cys | missense_variant | Exon 4 of 7 | ENST00000249806.11 | NP_060352.1 | |
CLN6 | NM_001411068.1 | c.541C>T | p.Arg181Cys | missense_variant | Exon 4 of 7 | NP_001397997.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLN6 | ENST00000249806.11 | c.445C>T | p.Arg149Cys | missense_variant | Exon 4 of 7 | 1 | NM_017882.3 | ENSP00000249806.5 | ||
ENSG00000260007 | ENST00000562767.2 | c.84-14088C>T | intron_variant | Intron 1 of 2 | 3 | ENSP00000456336.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251224Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135776
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461692Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727138
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74308
ClinVar
Submissions by phenotype
Neuronal ceroid lipofuscinosis Pathogenic:1Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 149 of the CLN6 protein (p.Arg149Cys). This variant is present in population databases (rs747229909, gnomAD 0.04%). This missense change has been observed in individual(s) with neuronal ceroid lipofuscinosis (PMID: 21990111, 31741823). ClinVar contains an entry for this variant (Variation ID: 457972). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects CLN6 function (PMID: 32171521). This variant disrupts the p.Arg149 amino acid residue in CLN6. Other variant(s) that disrupt this residue have been observed in individuals with CLN6-related conditions (PMID: 21549341, 30561534), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Variant summary: CLN6 c.445C>T (p.Arg149Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 251224 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in CLN6 causing Neuronal Ceroid-Lipofuscinosis (Batten Disease) (5.6e-05 vs 0.0011), allowing no conclusion about variant significance. c.445C>T has been reported in the literature as a non-informative genotype (second allele not specified) (example, Kousi_2012, Sleat_2016) and as a homozygous genotype in at-least three individuals (example Jiliani_2019) affected with Neuronal Ceroid-Lipofuscinosis (Batten Disease). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance citing overlapping but not all evidence utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Ceroid lipofuscinosis, neuronal, 6A;C5561927:Ceroid lipofuscinosis, neuronal, 6B (Kufs type) Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at